WS Audiology
Developing hearing aid and hearing-related products and services.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
* | N/A | Early VC | |
| Total Funding | 000k | ||
| EUR | 2019 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| % profit margin | (17 %) |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Formed in 2019, through the merger of Sivantos and Widex, WS Audiology combines more than 140 years’ experience in pioneering the use of technology to help people with hearing loss hear the sounds that make life wonderful. Today, one out of three hearing aids is made by us and we are active in over 125 markets, employing 11,000 people worldwide. Our broad portfolio of leading hearing-related products and services generates annual revenues of more than € 1.7 billion. WS Audiology is privately owned by the Tøpholm and Westermann families, as well as funds under the management of EQT and the Strüngmann family. As a global leader, our ambition is to unlock human potential by making wonderful sound part of everyone’s life.